Daily non-political popular news in brief.
OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy
06-02-2007 · EurekAlert!A researcher in the Oregon Health & Science University Cancer Institute and Portland Veterans Affairs Medical Center has found a way to identify which men need a second prostate biopsy because they may be harboring life-threatening prostate cancer even though they were given a clean bill of health after their first biopsy.
Read more »
Keywords: ohsu, cancer, institute, researchers, way, identify, men, biopsy, researcher
« Previous | Next »
Similar news on "OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy":
- VA researcher finds way to identify which men need a second biopsy
02-22-2007 · EurekAlert!
A researcher in the Oregon Health & Science University Cancer Institute and Portland Veterans Affairs Medical Center has found a way to identify which men need a second prostate biopsy because they may be harboring life-threatening prostate cancer even though they were given a clean bill of health after their first biopsy.
Similar news · Read more »
- OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival
06-01-2007 · EurekAlert!
Oregon Health & Science University Cancer Institute researchers have identified a protein that is a strong indicator of survival for men with advanced prostate cancer. The C-reactive protein, also known as CRP, is a special type of protein produced by the liver that is elevated in the presence of inflammation.
Similar news · Read more »
- OHSU Cancer Institute researcher develops test for targeted therapy in acute myeloid leukemia
12-10-2007 · EurekAlert!
Oregon Health & Science University Cancer Institute researcher Jeff Tyner, Ph.D., has created a way to identify proteins that are candidates for targeted therapy in acute myeloid leukemia using an assay that yields results in just four days.
Similar news · Read more »
- OHSU Cancer Institute researcher discovers what fuels certain cancer mutation
12-10-2007 · EurekAlert!
An Oregon Health & Science University Cancer Institute researcher has discovered that a particular hormone is responsible for driving a cancer enzyme to cause an often deadly red blood cell cancer. Researchers working with the cancer mutation in the JAK2 enzyme have found that the enzyme is dependent on the hormone TNF-alpha to grow and cause a red blood cell cancer called polycythemia vera, said principal investigator Thomas Bumm, M.D., Ph.D., OHSU Cancer Institute member.
Similar news · Read more »
- Gene markers located for hereditary prostate cancer
01-16-2008 · EurekAlert!
Researchers at the Johns Hopkins Brady Urological Institute, Wake Forest University and the Karolinska Institute in Sweden have identified an array of gene markers for hereditary prostate cancer that, along with family history for the disease, appear to raise risk to more than nine times that of men without such markers. The panel, gleaned from a study of more than 4,000 Swedes, found that these markers are common and could account for nearly half of the prostate cancer cases in this study.
Similar news · Read more »
- OHSU cancer institute researcher discovers new predictor of prostate cancer recurrence
02-14-2008 · EurekAlert!
An Oregon Health & Science University Cancer Institute researcher has found a biomarker that may help improve the ability to predict if a man's prostate cancer is going to come back after surgical removal.
Similar news · Read more »
- Stanford researchers identify immune dysfunction in melanoma patients
05-07-2007 · EurekAlert!
Researchers at Stanford have begun to shed light on why the human immune system isn't able to stop such cancers as melanoma, suggesting answers that could pave the way for better treatment of this often-fatal illness. In a small study, the scientists found that the immune cells in a majority of people with this deadly skin cancer fail to respond properly to a molecule called interferon, which normally activates the immune system.
Similar news · Read more »
- Emory researchers identify signaling protein for multiple myeloma
09-10-2007 · EurekAlert!
Researchers at Emory University's Winship Cancer Institute are the first to discover a mechanism that plays a critical role in the multiple myeloma cell cycle and survival. Their research may result in identification of a new therapeutic target for treating multiple myeloma.
Similar news · Read more »
- 'Network' approach identifies potential breast cancer susceptibility gene
10-09-2007 · EurekAlert!
Like a crossword-puzzle solver who uses the letters in some answers to figure out others, researchers at Dana-Farber Cancer Institute and an international group of collaborators have used data on genes involved in inherited forms of breast cancer to identify a gene linked to non-hereditary cases of the disease.
Similar news · Read more »
- M. D. Anderson researchers identify tumor-suppressor gene for lung cancer
11-13-2007 · EurekAlert!
The GPRC5A gene, which is under-expressed in human lung cancer cells, suppresses lung tumors in mouse models and could provide a key to attacking lung cancer in humans, researchers at the University of Texas M. D. Anderson Cancer Center report in the Nov. 21 edition of the Journal of the National Cancer Institute.
Similar news · Read more »
